MVEC’s influenza resources have been updated in line with ATAGI’s advice on seasonal influenza vaccines in 2022. Information contained in these pages includes dosing and brand advice (including information on cell-based vaccines), co-administration of influenza vaccines with other vaccines, recommendations in pregnancy, immunosuppressed individuals and the elderly, as well as eligibility for funded doses.

Our FAQ’s provide answers to commonly asked questions relating to influenza vaccines and their administration.

For more information please follow the links below:

MVEC: Influenza vaccine: frequently asked questions